In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of ...

Big food companies are starting to market to people on the powerful new obesity meds with labels that say "GLP-1 Friendly." ...

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they ...

GLP-1 medications have rapidly become some of the most influential treatments for Type 2 diabetes and weight loss. As more people look into these prescriptions, there is growing curiosity about how ...

Jay Campbell, the author of Metabolic Awakening with GLP-1 Peptides, aims to reshape the narrative behind GLP-1 peptides, not ...

Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

In addition to their weight loss benefits, GLP-1 RAs also act on neural circuits involved in appetite, impulse control, and ...

For restaurants and food companies, the increasing adoption of GLP-1 drugs present both an opportunity and a threat to their ...

Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...

A Stanford study shows simple digital prompts can motivate people taking GLP-1 medications to make lifestyle changes. It's a ...

Researchers at the University of Bristol have identified a specific biological mechanism by which GLP-1 drugs, the same class ...